Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Externer Link zu Navignostics AG
Tödistrasse 46
Horgen, Zurich 8810, CH
Navignostics AG hat dies direkt geteilt
Do you know that cancer treatment is never a one-size-fits-all approach for patients? In this Sejelas Founder-CEO Interview series, we hear from Dr. Jana Fischer, the Co-Founder and CEO at Navignostics AG. The team specialises in spatial single-cell proteomic tumour analysis for better cancer treatment. Read the full article here: https://lnkd.in/gcbhATci #diagnostics #cancer #tumour #lifescience #sejelas #founderceo #interviewseries
Navignostics AG is happy to now be a member of Swiss Medtech. We are looking forward to the knowledge exchange with the community. https://lnkd.in/dDzQuzkA
It was a pleasure to show our offices and labs to the interested visitors at our new location in Horgen. Thank you Stiftung grow!
Thank you Gwerbziitig Wädi for sharing the news of grow's annual event
Over the past two years Navignostics AG has grown a lot as a company and as a team. Therefore, we are happy to launch our new website to give a face to the people behind our solutions. All photos on the website are of our actual team doing our daily work in our Horgen labs. Please check out our beautiful new website at https://lnkd.in/dj2ir6tp and get a picture of how we support our clinical and research partners. Huge thanks to Angina Herrmann and Ave-Lii Idavain at Maend as well as to Rachael Camp for creating this fantastic website with us. It came out exactly as we hoped.
It's time for this year's public vote on the Top100 Swiss start-up award. You can vote for Navignostics with the following link: https://lnkd.in/etQ2jfjq Thank you so much for your support! <3 #TOP100SSU
Navignostics AG keeps on growing! We are very happy to welcome Mylène Blatter to the team. Mylène has profound experience as laboratory technician in the biotech industry. Her background and learnings drawn from working both in the context of established biopharma companies as well as young and developing start-ups are a great enrichment to our team. Welcome Mylène!
Navignostics AG does not stop growing! We are excited to welcome Ines Lüchtefeld to the team. Ines did her Ph.D. in Biomedical Engineering at ETH Zürich and then continued her postdoctoral research in personalized oncology using single organoid technology. Her interdisciplinary background in engineering, cancer biology and data analysis make her a prefect addition to our team. Welcome Ines!
We are excited to work with Standard BioTools and are looking forward to a fruitful collaboration!
Standard BioTools™ today announced a collaboration agreement with Navignostics AG for development of clinical research applications and service offerings using the Hyperion XTi™ Imaging System. This collaboration is pivotal in the fight against cancer, emphasizing the need for precision medicine strategies and robust technologies that offer critical biological insights to guide treatment decisions. Read the #pressrelease: https://lnkd.in/gyP79ZTb #clinicalresearch #precisionmedicine #imaging
Navignostics AG is growing some more! We are delighted to welcome Alexandra S. Eklund, PhD to the team. Alex did her PhD at the Max Planck Institute of Biochemistry where she investigated the spatial distribution of receptors involved in cancer signaling pathways. With her background in cancer research and excellent scientific track record, she is a fantastic addition to our team. Welcome Alex!
Navignostics AG is growing further! We are very excited to welcome Michelle Daniel to the team. We’ve had the pleasure of working alongside Michelle for many years back at the UZH Bodenmiller lab and are extremely happy that we could convince her to now join our Navignostics team. Michelle is an expert at highly multiplex protein imaging and her broad set of laboratory skills and in-depth knowledge of the Navignostics technology make her a perfect addition. It’s great to have you on the team Michelle!